| Ditemukan 570 dokumen dengan kata kunci 6401 |
Simpan CSV  |
|
Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?†
|
| No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1834-1840 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
|
| No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1841-1847 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|
| No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2206-2223 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|
| No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2206-2223 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
|
| No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.355-361 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
|
| No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.640-647 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, nodenegative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
|
| No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.618-624 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
|
| No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.1999-2004 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
|
| No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2005-20011 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
The Patient’s Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer
|
| No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1505-1512 | | Location: Perpustakaan FT |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Hasil Pencarian
